A Study Of Carbohydrate Counting Vs. Fixed Mealtime Insulin Dosing In Hospitalized Patients With Hyperglycemia

Overview

About this study

The purpose of this study is to determine if fixed mealtime dosing of rapid acting insulin achieves outcomes comparable to carbohydrate counting in hospitalized patients hyperglycemia and without Type 1 DM.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults ≥18 years; admitted to non-ICU units; require scheduled prandial insulin as part of basal–bolus insulin therapy with CC.

Exclusion Criteria:

  • History of type 1 DM

  • History of total pancreatectomy

  • Use of pre-admission CC for prandial insulin administration

  • Critical illness requiring ICU admission at time of recruitment.

  • Admission to psychiatry services

  • Pregnancy

  • All forms of enteral/tube feeding or parenteral nutrition at recruitment

  • Observation status at time of recruitment

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Sneha Mohan, M.B.B.S.

Contact us for the latest status

Contact information:

Melissa Wang

5072666911

wang.melissa@mayo.edu

More information

Publications

Publications are currently not available